Associate Director, Global Medical Writing (Publications) - Job ID : 1763

Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we’re advancing programs in Endocrinology Rare Disease and Oncology.

Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.

Guided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.

Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.

The Associate Director, Global Medical Writing, will be responsible for writing scientific publications connected with Ascendis’ clinical trials in endocrine indications. The role involves extensive cross‑functional collaboration with internal groups, including Clinical Development, Biostatistics, and Publication Planning, and with external investigators and researchers.

Key Responsibilities

• Draft, revise, and edit scientific publications, including manuscripts for peer‑reviewed journals as well as abstracts, posters, and oral presentations for medical conferences.
• Collaborate with Publication Planning team to coordinate kick‑off calls with investigators and establish timelines for the development of publications.
• Work with internal stakeholders to ensure publications are clear, accurate, and aligned with strategic goals.
• Participate in meetings with clinical trial investigators and key opinion leaders for the review and revision of drafts and to manage the editing and revision process, ensuring timely completion of scientific publications.
• Keep current with the latest information, trends, and developments in target therapy areas, and perform literature searches as needed for drafting publications. Interpret literature information relevant to scientific publications. Understand, assimilate, and interpret data and other sources of information with appropriate guidance / direction from authors and therapeutic teams.
• Remain current on industry and company requirements and best practices as they relate to scientific publications.
• Understand and follow applicable company publication policy and procedures and act as a subject matter expert regarding internal processes and relevant publication guidelines.
• MS / PhD / PharmD or 8+ years of experience writing scientific publications. Professional credentials / certification (e.g., CMPP) a plus.
• Familiarity with endocrinology and / or rare disease is a benefit but not required.
• Understanding of US and international regulations, requirements, and guidance associated with scientific publications (ICMJE, Good Publication Practice, etc).
• Ability to work directly from data outputs and clinical documents (protocols, CSRs, etc) to draft.
• Excellent communication skills and attention to detail; ability to assimilate and interpret scientific content and translate information for appropriate audiences.

The estimated salary range for this position is $170-185k. Actual salary determination is dependent on a variety of factors some of which include : experience, qualifications, and geographic location. This position may be eligible for a discretionary annual bonus or an incentive compensation plan (eligibility varies based on role and position level), discretionary stock‑based long‑term incentives, paid time off, and a comprehensive benefits package.

Ascendis Pharma is proud to be an equal opportunity employer. We are committed to creating an inclusive environment for all employees.

A note to recruiters :

We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from : Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs your ownership of these candidates will not be acknowledged.

#J-18808-Ljbffr